Daily Sabah logo

Politics
Diplomacy Legislation War On Terror EU Affairs Elections News Analysis
TÜRKİYE
Istanbul Education Investigations Minorities Expat Corner Diaspora
World
Mid-East Europe Americas Asia Pacific Africa Syrian Crisis Islamophobia
Business
Automotive Economy Energy Finance Tourism Tech Defense Transportation News Analysis
Lifestyle
Health Environment Travel Food Fashion Science Religion History Feature Expat Corner
Arts
Cinema Music Events Portrait Reviews Performing Arts
Sports
Football Basketball Motorsports Tennis
Opinion
Columns Op-Ed Reader's Corner Editorial
PHOTO GALLERY
JOBS ABOUT US RSS PRIVACY CONTACT US
© Turkuvaz Haberleşme ve Yayıncılık 2023

Daily Sabah logo

عربي
  • Politics
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • Elections
    • News Analysis
  • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Expat Corner
    • Diaspora
  • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • Islamophobia
  • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
  • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
  • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Reviews
    • Performing Arts
  • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
  • Gallery
  • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
  • TV
  • World
  • Mid-East
  • Europe
  • Americas
  • Asia Pacific
  • Africa
  • Syrian Crisis
  • Islamophobia

S. Korea to purchase 70,000 courses of new Pfizer COVID-19 pill

by REUTERS

SEOUL Nov 06, 2021 - 4:23 pm GMT+3
In this Nov. 23, 2015, file photo, a man enters Pfizer's world headquarters, in New York City, U.S. (AP Photo)
In this Nov. 23, 2015, file photo, a man enters Pfizer's world headquarters, in New York City, U.S. (AP Photo)
by REUTERS Nov 06, 2021 4:23 pm
RECOMMENDED
Pakistan's Gen. Pervez Musharraf at the Joint Staff Headquarters, Rawalpindi, Pakistan, Nov. 27, 2007. (Reuters Photo)

Pakistani ex-military ruler Pervez Musharraf dies in Dubai exile

Pervez-Musharraf

South Korea has agreed to buy 70,000 courses of Pfizer Inc.'s experimental antiviral COVID-19 pill, the Korea Disease Control and Prevention Agency (KDCA) said on Saturday.

Pfizer on Friday said trial results showed that its Paxlovid pill reduced by 89% the risk of hospitalization or death in patients at high risk of severe illness within three days of the onset of coronavirus symptoms.

South Korea has already signed agreements to secure 200,000 courses of Merck & Co. Inc.'s COVID-19 treatment. It is looking to buy an additional 134,000 courses, though it is undecided of which treatment, KDCA said.

Last month, the government said it was in talks with Swiss pharmaceutical Roche Holding AG, which is developing an easy-to-administer antiviral pill for COVID-19.

The government had allocated a budget of 36.2 billion won ($30.63 million) for oral COVID-19 antiviral pills.

Pfizer is in talks with 90 countries over supply contracts for Paxlovid, Chief Executive Officer Albert Bourla said in an interview on Friday.

The U.K. has already secured 480,000 courses of Merck's drug and procured 250,000 courses of the Pfizer treatment.

Pfizer said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market.

Currently, all COVID-19 treatments used in the U.S. require an IV or injection. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration (FDA) after showing strong initial results, and on Thursday the United Kingdom became the first country to OK it.

Pfizer said it will ask the FDA and international regulators to authorize its pill as soon as possible after independent experts recommended halting the company’s study based on the strength of its results. Once Pfizer applies, the FDA could make a decision in as little as weeks.

RECOMMENDED
Pakistan's Gen. Pervez Musharraf at the Joint Staff Headquarters, Rawalpindi, Pakistan, Nov. 27, 2007. (Reuters Photo)

Pakistani ex-military ruler Pervez Musharraf dies in Dubai exile

Pervez-Musharraf
  • shortlink copied
  • Last Update: Nov 08, 2021 11:56 am
    RELATED TOPICS
    fight-against-terrorism DEUTSCHE-BANK US-LIBYA-RELATIONS
    KEYWORDS
    pfizer covid-19 pandemic covid-19 drugs south korea
    The Daily Sabah Newsletter
    Keep up to date with what’s happening in Turkey, it’s region and the world.
    You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
    A Turkish Airlines aircraft is seen as a snow plow cleans runway at Istanbul Airport, Istanbul, Türkiye, Jan. 24, 2022. (DHA Photo)

    Over 200 flights cancelled in Istanbul due to expected snowstorm

    snowstorm
    A view of the rubble of a building hit by the earthquake in Pazarcık, Kahramanmaraş, Feb. 6, 2023. (AA Photo)

    Death toll rises to 1,498 after magnitude 7.7 quake rocks SE Türkiye

    EARTHQUAKE

    Gaziantep Castle collapses after magnitude 7.7 quake hit Türkiye

    EARTHQUAKE

    Kahramanmaraş, Hatay, Gaziantep suspend flights after 7.7 earthquake

    EARTHQUAKE
    No Image
    Turn it upside down: Have a look at the topsy-turvy house
    PHOTOGALLERY
    • POLITICS
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • News Analysis
    • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Diaspora
    • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • İslamophobia
    • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
    • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
    • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Performing Arts
    • Reviews
    • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
    • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
    • Photo gallery
    • Jobs
    • privacy
    • about us
    • contact us
    • RSS
    © Turkuvaz Haberleşme ve Yayıncılık 2021